| Ms Mary Kathryn Mccracken, MA, CCC-SLP | |
|
15600 San Pedro Ave, Suite 307, San Antonio, TX 78232-3740 | |
| (800) 437-7560 | |
| Not Available |
| Full Name | Ms Mary Kathryn Mccracken |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 15600 San Pedro Ave, San Antonio, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013031558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 100094 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Mary Kathryn Mccracken, MA, CCC-SLP 9411 Marsh Creek Dr, San Antonio, TX 78250-3529 Ph: (210) 842-0321 | Ms Mary Kathryn Mccracken, MA, CCC-SLP 15600 San Pedro Ave, Suite 307, San Antonio, TX 78232-3740 Ph: (800) 437-7560 |
News Archive
In the first study of its kind, lay health workers increased screening rates for hepatitis B virus (HBV) and knowledge about the disease among a group of Asian Americans, known as the Hmong, UC Davis researchers have found.
The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership leading the development of new and affordable tuberculosis (TB) drugs, announced today a new grant and pledge of up to $40 million over the next five years from the United States Agency for International Development (USAID).
In a randomized controlled trial of 134 mildly stressed, middle-aged to older adults, participants who were assigned to a six-week mindfulness-meditation training program experienced significantly reduced negative affect variability—which refers to subjective distress and includes a range of mood states such as worry, anxiety, anger, self-criticism, and life dissatisfaction—compared with participants assigned to a waitlist control.
Patients with advanced non-small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard second-line erlotinib therapy, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
› Verified 7 days ago
Miss Julia Shad, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7390 Barlite Blvd Ste315, San Antonio, TX 78224 Phone: 210-787-1583 | |
Anne Wright, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4775 Hamilton Wolfe Rd Ste 1, San Antonio, TX 78229 Phone: 210-616-0283 Fax: 210-616-0071 | |
Robin Coop, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2203 Babcock Rd, San Antonio, TX 78229 Phone: 210-614-3911 Fax: 210-616-0443 | |
Mrs. Shara Renee De Los Santos, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Central Pkwy S, San Antonio, TX 78232 Phone: 121-079-8227 | |
Karen Coulter, CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2203 Babcock Rd, San Antonio, TX 78229 Phone: 210-614-3911 Fax: 210-616-0443 | |
Jesus Huerta Jr., Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 98 Briggs St, Suite 990, San Antonio, TX 78224 Phone: 210-226-9536 Fax: 817-789-6849 | |
Clarissa Fernandez, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10609 Ih 10 W, Suite 201, San Antonio, TX 78230 Phone: 210-344-5437 Fax: 210-340-1259 |